Poster Presentations
(Click on the links under the title to view the presentations and abstracts)
If you would like to contact the author, please download the contact information HERE.
|
LAST NAME |
FIRST NAME |
TITLE |
|
ADILI |
ALI |
IL-10 IN TRIPLE NEGATIVE METASTATIC BREAST CANCER |
|
AGGARWAL |
VAISHALI |
INTERFERON-Γ, A MASTER REGULATOR DRIVING IMMUNE RESPONSE |
|
AHMED |
AML |
STUDY OF PI3K ONCOGENE ADDICTION IN NON-SMALL CELL LUNG |
|
BHATIA |
ISHAN |
HELPING TO DEVELOP NOVEL CAR-T CELL THERAPY FOR PEDIATRIC ACUTE |
|
CHAKRABORTY |
SRIJA |
ENHANCING NATURAL KILLER CELL HOMING TO MELANOMA ORGANOIDS |
|
CHEN |
YU-HIS |
TITERING CAR EXPRESSION ON PRIMARY T CELLS ENABLED BY MICROFLUIDIC |
|
CHOUKRANI |
GHIZLANE |
GALECTIN-9 SHIFTS THE PHAGOCYTIC BALANCE ON CANCER CELLS AND TRIGGERS |
|
CHUKWUKERE |
CHINAZAEKPERE |
IMMUNOTHERAPY - PINEAPPLE, AND COLOSTRUM FROM BREASTMILK CAN |
|
DAR |
MUKHTAR AHMAD |
DESIGNING OF PEPTIDE BASED MULTI-EPITOPE VACCINE CONSTRUCT AGAINST |
|
GUNTURI |
ALEKHYA |
CHARACTERIZATION OF NOVEL ANTI-TIGIT ANTIBODIES FOR POTENTIAL ANTI-TUMOR |
|
HAGAR |
AMIT |
AN INTEGRATED VIRTUAL TISSUE PLATFORM FOR INCORPORATING EXERCISE ONCOLOGY |
|
HUANG |
YUE |
MESOPOROUS SILICA NANOPARTICLES AS ROS SENSITIVE CARRIER FOR THERAVAC |
|
JALBUENA |
AMANGELIN |
DEFINING T-CELL RESPONSES TO MUTANT AND NON-MUTANT ANTIGENS IN |
|
KARALIOTA |
SEVASTI |
HETERODIMERIC IL-15 (HETIL-15) IMMUNOTHERAPY REVERSES CD8+T CELL METABOLIC |
|
KNIGHT |
JULIA |
ALDH INHIBITION AS MODULATOR OF OVARIAN TUMOR ASSOCIATED MACROPHAGES |
|
KONDURI |
VANAJA |
DENDRITIC CELL GOVERNANCE OF AN INNATE-LIKE CYTOTOXIC EFFECTOR MEMORY |
|
LEYFMAN |
YAN |
IMPROVING HEALTHCARE ACCESS THROUGH THE DEVELOPMENT OF AN ONTOLOGY |
|
LIU |
WENLONG |
ANTI-MESOTHELIN IMMUNOTOXIN LMB-100 INDUCES COMPLETE TUMOR REGRESSIONS |
|
MAJUMDAR |
SHUBHABRATA |
FINE-TUNING CHIMERIC ANTIGEN RECEPTOR SIGNALING BY REDUCING CD3Ζ ITAM DIVERSITY |
|
MARLIN ANDREWS |
CELINE |
HARNESSING THE INNATE IMMUNE RESPONSE FOR POTENTIAL MALIGNANT |
|
MARTIN |
SUNIL |
EXPANSION AND TRANSDUCTION OF HUMAN Γ9Δ2 T CELLS TO TARGET |
|
MASTROPAOLO |
MARIA |
PATIENT-DERIVED ORGANOIDS MODEL SENSITIVITY AND RESISTANCE TO PARP |
|
MHIBIK |
MAISSA |
TREATMENT WITH BTK INHIBITOR OR BCL-2 INHIBITOR ENHANCES CYTOTOXICITY OF THE |
|
MOHANTY |
AYUSHI |
COMBINED DRUG EFFICACY IN PRECLINICAL MODELS OF COLORECTAL CANCER |
|
MOORE |
EMILY |
PAG Facilitates Immune Synapse Organization and PD-1 Function |
|
MUELLER |
JUERGEN |
DELETION OF NK CELLS AND RE-DIRECTING OF DENDRITIC CELL DIFFERENTIATION DURING |
|
NAHAR |
SAIFUN |
EFFECTIVE IMMUNOTHERAPEUTIC REGIMEN WITH COMBINATIONS OF TLR |
|
NCEMBU |
SIKOZILE |
RECOMBINANT CD-64 DIRECTED SINGLE-CHAIN ANTIBODY FUSION PROTEIN |
|
NISAR |
ALBEENA |
IMPLEMENTING FAST TRACK COST-EFFECTIVE PROCESS DEVELOPMENTAL |
|
ONDA |
MASANORI |
15B6 CAR T CELLS THAT BIND TO A JUXTAMEMBRANE REGION OF MESOTHELIN |
|
OUCHEN |
KHAOULA |
OPTIMIZED LENTIVIRAL VECTOR DESIGN FOR ON-COMMAND GENE-CARGO |
|
PATKAR |
SUSHANT |
TUMOR MICROENVIRONMENT (TME) LANDSCAPE DICTATES METASTATIC |
|
PRITAM |
MANISHA |
DEVELOPMENT OF LAG3 IMMUNE CHECKPOINT INHIBITORS FOR CANCER |
|
SANYAL |
SREYA |
IMMUNOLOGICAL FEATURES AFFECTING GASTRIC TUMOR SENSITIVITY |
|
SMITH-UFFEN |
MEGAN |
ESTIMATING SCENARIOS FOR SURVIVAL TIME IN PATIENTS WITH |
|
SMITH-UFFEN |
MEGAN |
IMMUNE CHECKPOINT INHIBITOR-INDUCED POLYARTHRITIS: A CASE SERIES |
|
STRAVOKEFALOU |
VASILIKI |
REDUCTION OF CIRCULATING TUMOR CELLS AND METASTASIS FORMATION |
|
UGUZOVA |
SABINE |
PREDICTIVE VALUE OF CT SCANS AT 3 AND 6 MONTHS ON OVERALL SURVIVAL |
|
VIGANT |
FREDERIC |
IN VIVO GENERATION OF TUMOR-METABOLISM-REGULATED HER-2-SPECIFIC |
|
VOYNOVA |
ELISAVETA |
INCREASED ACTIVITY OF A NK-SPECIFIC CAR-NK FRAMEWORK TARGETING CD3 AND |
|
WANG |
BINBIN |
DECOUPLING CYTOTOXIC T LYMPHOCYTE AND EXHAUSTED T LYMPHOCYTE |
|
WARD |
ROSS |
INFLAMMASONE ACTIVATING NANOPARTICLES PROMOTE |
|
YOSHIMOTO |
SHO |
PD-1CD28 SWITCH RECEPTOR OVERCOMES PD-L1 MEDIATED |
|
ZENS |
STEFAN |
CHARTING THE TUMOR-REACTIVE T CELL REPERTOIRE IN DNA DAMAGE |